390 results on '"Leach, Steven T."'
Search Results
2. School Students with Chronic Illness Have Unmet Academic, Social, and Emotional School Needs
3. Facilitating Engagement with School in Students with Chronic Illness through Positive Education: A Mixed-Methods Comparison Study
4. Reply to "Proton pump inhibitors and esophageal atresia: Too early to change clinical practice".
5. Proton pump inhibitors, antibiotics, and atopy increase the risk of eosinophilic esophagitis in children with esophageal atresia
6. Dietary Emulsifier Exposure in People With Inflammatory Bowel Disease Compared With Healthy Controls: Is There a Cause for Concern?
7. Role of Probiotics and Prebiotics in Gut Symbiosis
8. MAST CELLS IN THE MILIEU: A COMPARATIVE STUDY IN THE TONGUE AND LIVER
9. Associations Among Mucosal and Transmural Healing and Fecal Level of Calprotectin in Children With Crohn’s Disease
10. Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old
11. Evolution of a Pathogenic Microbiome
12. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse
13. Age-dependent variation of fecal calprotectin in cystic fibrosis and healthy children
14. Advancing nutritional therapy: A novel polymeric formulation attenuates intestinal inflammation in a murine colitis model and suppresses pro-inflammatory cytokine production in ex-vivo cultured inflamed colonic biopsies
15. Fecal Markers of Inflammation and Disease Activity in Paediatric Crohnʼs Disease: Results from the ImageKids Study
16. Enzyme-Linked Immunosorbent Assay to Measure S100A12 in Fecal Samples of Children and Adults
17. Letter to the Editor Re: Serum Calprotectin in Adolescents With Inflammatory Bowel Disease
18. Intestinal dysbiosis and inflammation in children with repaired esophageal atresia.
19. Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study
20. Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review
21. Changes to the upper gastrointestinal microbiotas of children with reflux oesophagitis and oesophageal metaplasia
22. 283. DOES PROTON PUMP INHIBITOR EXPOSURE INCREASE THE RISK OF DEVELOPING EOSINOPHILIC ESOPHAGITIS IN CHILDREN WITH ESOPHAGEAL ATRESIA?
23. Exploring and Enhancing the Anti-Inflammatory Properties of Polymeric Formula
24. Fecal biomarkers in inflammatory bowel disease
25. Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis
26. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response?
27. Fecal Calprotectin, Chitinase 3-Like-1, S100A12 and Osteoprotegerin as Markers of Disease Activity in Children with Crohn’s Disease
28. Blenderised Tube Feeds vs. Commercial Formula: Which Is Better for Gastrostomy-Fed Children?
29. Evaluating the Dietary Intake of Children With Esophageal Atresia: A Prospective, Controlled, Observational Study
30. Host Attachment, Invasion, and Stimulation of Proinflammatory Cytokines by Campylobacter concisus and Other Non—Campylobacter jejuni Campylobacter Species
31. Editorial: Health informatics in pediatric gastroenterology, hepatology & nutrition.
32. Mo1603: ENRICHMENT OF PREVOTELLA IS A CONSISTENT SIGNATURE IN THE METAPLASTIC ESOPHAGUS IN CHILDREN AND ADULTS
33. 32: BLENDERISED TUBE FEEDING VS FORMULA FEEDING: WHICH IS BETTER FOR TUBE-FED CHILDREN?
34. 343 ARE AIRWAY MICROBIOTA AND INFLAMMATION IN CHILDREN WITH ESOPHAGEAL ATRESIA RELATED TO REFLUX ASPIRATION?
35. Severe Pediatric Ulcerative Colitis: A Prospective Multicenter Study of Outcomes and Predictors of Response
36. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: A clue to the increased risk of intestinal malignancy in adulthood?
37. Faecal levels of zonula occludens toxin in paediatric patients with Crohnʼs disease and their association with the intestinal microbiota
38. Osteoprotegerin Exerts Its Pro-inflammatory Effects Through Nuclear Factor-κB Activation
39. An update of the role of nutritional therapy in the management of Crohn’s disease
40. Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model
41. Vitamin D Deficiency in Children with Inflammatory Bowel Disease
42. Effect of Exclusive Enteral Nutrition on the Microbiota of Children With Newly Diagnosed Crohnʼs Disease
43. Subclinical Intestinal Inflammation in Siblings of Children with Crohn’s Disease
44. Effect of exclusive enteral nutrition on bone turnover in children with Crohn’s disease
45. C-Reactive Protein and Disease Activity in Children with Crohn’s Disease
46. Low rate of inflammatory bowel disease in the Australian indigenous paediatric population
47. Manipulating the neonatal gut microbiome: current understanding and future perspectives
48. Polymeric Formula Has Direct Anti-Inflammatory Effects on Enterocytes in an in VitroModel of Intestinal Inflammation
49. Campylobacter concisus and exotoxin 9 levels in paediatric patients with Crohnʼs disease and their association with the intestinal microbiota
50. Manipulating the neonatal gut microbiome: current understanding and future perspectives.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.